BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12904833)

  • 1. Mortality and morbidity associated with osteoporosis drug treatment following hip fracture.
    Cree MW; Juby AG; Carriere KC
    Osteoporos Int; 2003 Sep; 14(9):722-7. PubMed ID: 12904833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do patients receive recommended treatment of osteoporosis following hip fracture in primary care?
    Petrella RJ; Jones TJ
    BMC Fam Pract; 2006 May; 7():31. PubMed ID: 16684358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of osteoporosis treatment in seniors after hip fracture.
    Juby AG; De Geus-Wenceslau CM
    Osteoporos Int; 2002 Mar; 13(3):205-10. PubMed ID: 11991439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missed opportunities for osteoporosis treatment in patients hospitalized for hip fracture.
    Jennings LA; Auerbach AD; Maselli J; Pekow PS; Lindenauer PK; Lee SJ
    J Am Geriatr Soc; 2010 Apr; 58(4):650-7. PubMed ID: 20398147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interventions to improve osteoporosis treatment following hip fracture. A prospective, randomized trial.
    Gardner MJ; Brophy RH; Demetrakopoulos D; Koob J; Hong R; Rana A; Lin JT; Lane JM
    J Bone Joint Surg Am; 2005 Jan; 87(1):3-7. PubMed ID: 15634808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of antiresorptive agents in the prevention of recurrent hip fractures.
    Morin S; Rahme E; Behlouli H; Tenenhouse A; Goltzman D; Pilote L
    Osteoporos Int; 2007 Dec; 18(12):1625-32. PubMed ID: 17634854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in the undertreatment of osteoporosis following hip fracture.
    Gardner MJ; Flik KR; Mooar P; Lane JM
    J Bone Joint Surg Am; 2002 Aug; 84(8):1342-8. PubMed ID: 12177263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of fractures in older people who fall.
    Unsworth J
    Br J Community Nurs; 2003 Jul; 8(7):308-13. PubMed ID: 12920465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low frequency of treatment of osteoporosis among postmenopausal women following a fracture.
    Andrade SE; Majumdar SR; Chan KA; Buist DS; Go AS; Goodman M; Smith DH; Platt R; Gurwitz JH
    Arch Intern Med; 2003 Sep; 163(17):2052-7. PubMed ID: 14504118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of postmenopausal osteoporosis and the prevention of fractures.
    Gambacciani M; Levancini M
    Panminerva Med; 2014 Jun; 56(2):115-31. PubMed ID: 24942322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends and determinants of antiresorptive drug use for osteoporosis among elderly women.
    Perreault S; Dragomir A; Desgagné A; Blais L; Rossignol M; Blouin J; Moride Y; Ste-Marie LG; Fernandès JC
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):685-95. PubMed ID: 15645517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 7: Treatment of osteoporosis: why, whom, when and how to treat. The single most important consideration is the individual's absolute risk of fracture.
    Seeman E; Eisman JA
    Med J Aust; 2004 Mar; 180(6):298-303. PubMed ID: 15012571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inpatient consultation approach to osteoporosis treatment in patients with a fracture. Is automatic consultation needed?
    Streeten EA; Mohamed A; Gandhi A; Orwig D; Sack P; Sterling R; Pellegrini VD
    J Bone Joint Surg Am; 2006 Sep; 88(9):1968-74. PubMed ID: 16951113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risks for cancer associated with use of calcitonin, bisphosphonates or selective estrogen receptor modulators among osteoporosis patients: a population-based cohort study.
    Hsiao FY; Hsu WW
    Jpn J Clin Oncol; 2017 Oct; 47(10):935-941. PubMed ID: 28981741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Postmenopausal osteoporosis].
    László A
    Orv Hetil; 2004 Jan; 145(1):3-13. PubMed ID: 15222134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of subsidizing effective anti-osteoporosis drugs on compliance with management guidelines in patients following low-impact fractures.
    Liel Y; Castel H; Bonneh DY
    Osteoporos Int; 2003 Jul; 14(6):490-5. PubMed ID: 12730761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The management of osteoporosis following hip fracture: have we improved our care?
    Bahl S; Coates PS; Greenspan SL
    Osteoporos Int; 2003 Nov; 14(11):884-8. PubMed ID: 14569422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging bone and osteoporosis: strategies for preventing fractures in the elderly.
    Ettinger MP
    Arch Intern Med; 2003 Oct; 163(18):2237-46. PubMed ID: 14557222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A good combination to achieve a reduced number of fractures: bone density measurements, drug therapy and hip protector].
    Johnell O; Ljunggren O; Mellström D
    Lakartidningen; 2001 Jul; 98(28-29):3204-6. PubMed ID: 11496807
    [No Abstract]   [Full Text] [Related]  

  • 20. Osteoporosis: a review and its dental implications.
    Mattson JS; Cerutis DR; Parrish LC
    Compend Contin Educ Dent; 2002 Nov; 23(11):1001-4, 1006, 1008 passim; quiz 1014. PubMed ID: 12526189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.